Evidence map›Paper›PMID 33815807›Full record

ArticleNew microbes and new infections2021

TRIzol-based RNA extraction for detection protocol for SARS-CoV-2 of coronavirus disease 2019.

A Amirouche, D Ait-Ali, H Nouri, L Boudrahme-Hannou, S Tliba, A Ghidouche, I Bitam

Open access · goldAbstract read
In one paragraph

Article in New microbes and new infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

A AmiroucheLaboratoire de Biochimie Appliquée, CHU de Bejaia, Bejaia, Algeria.
D Ait-AliFaculté des Sciences de la Nature et de la Vie, CHU de Bejaia, Bejaia, Algeria.
H NouriFaculté des Sciences de la Nature et de la Vie, CHU de Bejaia, Bejaia, Algeria.
L Boudrahme-HannouLaboratoire de Génie Biologique des Cancers, CHU de Bejaia, Bejaia, Algeria.
S TlibaLaboratoire de Génie Biologique des Cancers, CHU de Bejaia, Bejaia, Algeria.
A GhidoucheFaculté des Sciences de la Nature et de la Vie, CHU de Bejaia, Bejaia, Algeria.
I BitamEcole Supérieure en Sciences de l'Aliment et des Industries Agroalimentaires (ESSAIA), El Harrach, Alger, Algeria.
University of Béjaïa · DZÉcole Nationale Supérieure Agronomique · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnostic testing is important for managing the 2019 novel coronavirus (SARS-CoV-2). We developed an optimized protocol for SARS-CoV-2 RNA extraction from the surface of the respiratory mucosa with nasopharyngeal swabs and compared the sensitivity of RNA extraction methods. RNA extraction was performed using three different procedures (TRIzol, QIAamp, VMT-TRIzol) from nine positive SARS-CoV-2 samples. SARS-CoV-2 was detected by real-time reverse transcriptase PCR (RT-PCR) using a detection kit for SARS-CoV-2 (Sun Yat-sen University). Compared to RT-PCR results, there were no discernible differences in detection rates when comparing the three different extraction procedures. On the basis of these results, the use of TRIzol as a transport medium and RNA extraction method for SARS-CoV-2 detection may be a helpful alternative for laboratories facing shortages of commercial testing kits.

Indexed as

Diagnostic techniquesRT-PCRSARS-CoV-2throat swabTRIzol

Identifiers

PMID33815807
PMCPMC8010344
OpenAlexW3144833188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.